Test Price
2,800 AED✅ Home Collection Available
RASA1 Gene Genetic Test for Capillary Malformation-Arteriovenous Malformation in UAE | 2800 AED
Executive Summary & Core Metrics
Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Included Telephonic Post-Test Clinical Guidance with a DHA-licensed genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
The RASA1 NGS test delivers definitive molecular diagnosis for Capillary Malformation-Arteriovenous Malformation syndrome using full-gene sequencing with 99.9% analytical sensitivity. All procedures operate under ISO 9001:2015 certification and comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Test Overview & Methodology
The RASA1 Gene NGS Test utilises Next Generation Sequencing to comprehensively screen the entire RASA1 gene for pathogenic variants linked to Capillary Malformation-Arteriovenous Malformation (CM-AVM) syndrome, providing a definitive molecular diagnosis with industry-leading speed and precision. This advanced genetic test detects disease-causing mutations across full coding regions, splice sites, and deep intronic regions, enabling accurate identification of SNVs, indels, and copy number variants.
| Feature | Our RASA1 NGS Test | Standard Single-Gene Test |
|---|---|---|
| Technology | Next Generation Sequencing (NGS) | Sanger Sequencing |
| Gene Coverage | Full coding regions, splice sites, deep intronic regions | Select exons only |
| Turnaround Time | 3 – 4 Weeks | 6 – 8 Weeks |
| Price | 2800 AED | ~3500 AED |
| Analytical Sensitivity | 99.9% (NGS validation) | ~90% |
| Variant Detection | SNVs, indels, CNVs | SNVs and small indels only |
Physician Insight & Safety Protocols
"A molecular diagnosis for CM-AVM empowers patients and families with actionable information for surveillance and management. However, genetic results must always be integrated with clinical examination and family history. I recommend every individual considering this test to undergo pre-test genetic counselling to fully understand the implications for themselves and their relatives."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication & Clinical Management
Do not discontinue any prescribed medication without consulting your doctor. This test does not replace clinical monitoring or therapeutic management. Results should be reviewed with a qualified physician to guide any changes in care.
Exclusion Criteria
- Minors (under 18) without explicit, documented consent from a parent or legal guardian in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Individuals unable to provide voluntary informed consent due to cognitive impairment or language barriers without an authorised interpreter.
- Patients with uncontrolled bleeding disorders where venepuncture may be hazardous (alternative sample: single drop of blood on FTA card may be considered after physician approval).
Emergency Red Flags After Sample Collection
If you experience sudden severe headache, visual disturbances, unexplained bruising or bleeding, or signs of stroke (facial droop, arm weakness, speech difficulty), seek immediate emergency medical care. These are not expected reactions to a routine blood draw but must be evaluated urgently.
Patient FAQ & Clinical Guidance
1. What does the RASA1 NGS test detect and how long do results take?
The RASA1 NGS test identifies disease-causing mutations in the RASA1 gene associated with capillary malformation-arteriovenous malformation syndrome, delivering a comprehensive report within 3 to 4 weeks. Our laboratory uses full-gene sequencing with copy number variation analysis, offering a definitive molecular diagnosis that can guide treatment decisions, family screening, and pregnancy planning. Turnaround time begins once the sample arrives at our ISO-certified facility, and you will receive a telephonic interpretation session upon release.
2. Is home sample collection available across all Emirates?
Certified phlebotomists provide hospital-grade home collection in Dubai, Abu Dhabi, Sharjah, Ajman, Ras Al Khaimah, Fujairah, and Umm Al Quwain from 8 AM to 11 PM, with strict cold-chain transport. The service complies with DHA mobile health standards, and your sample is logged into our LIMS immediately, maintaining chain of custody. Please WhatsApp +971 54 548 8731 to confirm your address and preferred time slot.
3. Can I use my health insurance to cover this test?
Many UAE insurers now partially or fully reimburse genetic testing when medically indicated; we provide direct billing verification and a detailed pre-authorisation letter via WhatsApp. Send your insurance card copy to +971 54 548 8731, and our team will check your policy's coverage for hereditary vascular malformation screening. For cash-pay patients, the all-inclusive price is 2800 AED, which includes genetic counselling, sample collection, and post-guidance.
4. What pre-test preparation is required before sample collection?
A detailed clinical history must be documented and a genetic counselling session is mandatory to construct a three-generation pedigree chart highlighting any family members affected by vascular malformations. Acceptable sample types include whole blood (EDTA tube), extracted DNA, or a single drop of blood on an FTA card. All samples are processed using ISO 9001:2015 cold-chain logistics.
UAE Regulatory & Data Privacy Adherence
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): Your genomic data is stored encrypted, anonymised, and never shared without explicit consent.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: All electronic health records and genetic test data are managed under strict ICT security protocols.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Genetic testing adheres to rigorous informed consent standards and reporting obligations.
- ISO 9001:2015 Certified Facility (Cert: INT/EGQ/2509DA/3139), DHA/MOHAP compliant nomenclature.
Clinical & Logistical Metadata
| Test Name | RASA1 Gene NGS Test for Capillary Malformation-Arteriovenous Malformation |
| Price (AED) | 2800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Whole blood (EDTA tube), extracted DNA, or FTA card blood spot |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | Q27.3 |
| LOINC Code | 50398-7 |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
For appointments or inquiries: +971 54 548 8731 (WhatsApp & Call) | DHA Facility License: 1143
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | UAE DHA/MOHAP Compliant
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians